Predicting survival among patients listed for liver transplantation: an assessment of serial MELD measurements.
about
Advances in liver transplantation allocation systemsModel for End-stage Liver DiseaseLimitations of the MELD score in predicting mortality or need for removal from waiting list in patients awaiting liver transplantation.Longitudinal assessment of prognostic factors for patients with hepatorenal syndrome in a tertiary centerSurvival and prognostic factors in hepatitis B virus-related acute-on-chronic liver failure.REpeated AutoLogous Infusions of STem cells In Cirrhosis (REALISTIC): a multicentre, phase II, open-label, randomised controlled trial of repeated autologous infusions of granulocyte colony-stimulating factor (GCSF) mobilised CD133+ bone marrow stemIncreasing disparity in waitlist mortality rates with increased model for end-stage liver disease scores for candidates with hepatocellular carcinoma versus candidates without hepatocellular carcinoma.MELD Score Kinetics in Decompensated HIV+/HCV+ Patients: A Useful Prognostic Tool (ANRS HC EP 25 PRETHEVIC Cohort Study).Model for end-stage liver disease: end of the first decade.Comparison of the ability of the PDD-ICG clearance test, CTP, MELD, and MELD-Na to predict short-term and medium-term mortality in patients with decompensated hepatitis B cirrhosis.An acute change in lung allocation score and survival after lung transplantation: a cohort study.Important predictor of mortality in patients with end-stage liver disease.Impact of dynamic changes in MELD score on survival after liver transplantation - a Eurotransplant registry analysis.MELD-good for many, not as good for others … at least for now.Elevated expression of tumour necrosis factor-α-induced protein 8 (TNFAIP8)-like 2 mRNA in peripheral blood mononuclear cells is associated with disease progression of acute-on-chronic hepatitis B liver failure.The evolution in the prioritization for liver transplantation.The aggressive phenotype revisited: utilization of higher-risk liver allografts.Higher Mortality in registrants with sudden model for end-stage liver disease increase: Disadvantaged by the current allocation policy.Value of the model for end-stage liver disease for predicting survival in hepatocellular carcinoma patients treated with transarterial chemoembolization.Delta model for end-stage liver disease and delta clinical prognostic indicator as predictors of mortality in patients with viral acute liver failure.Ascites Neutrophil Gelatinase-Associated Lipocalin Identifies Spontaneous Bacterial Peritonitis and Predicts Mortality in Hospitalized Patients with Cirrhosis.Dynamic changes in MELD score not only predict survival on the waiting list but also overall survival after liver transplantation.Transjugular intrahepatic portosystemic shunt does not independently increase risk of death in high model for end stage liver disease patients.The value of MELD and sodium in assessing potential liver transplant recipients in the United Kingdom.Increased frequency of circulating Th17 cells in acute-on-chronic hepatitis B liver failure.Liver transplantation with the Meld system: a prospective study from a single European centerMacrocytic anemia is associated with the severity of liver impairment in patients with hepatitis B virus-related decompensated cirrhosis: a retrospective cross-sectional study
P2860
Q26766076-BC97A5EA-D7C9-4E72-B5E5-E5BF75D4201FQ26864971-58E21112-989F-4530-87EE-298BBBB45A84Q33506549-BC3FFD0E-D936-4FFB-81CC-A4731612D795Q33977165-8E9A63C4-1B00-48A3-B277-F56C65F89D44Q35178097-2C528D76-4D66-4A49-A643-8ADC8FEF1505Q35203746-C0B5459A-3F18-497E-A6C3-BF0244A3B7A2Q35869964-1E38D8EC-DEA5-4903-92FE-211C36942B2FQ36009355-E6EA7BE5-32A4-41AC-973A-1ECA08921081Q36588122-99E79E07-1323-4627-9796-6645713626C8Q36648772-108EF782-82AE-48E9-92C3-FB2BB563C3CFQ37285800-AA29A824-C76C-477F-A657-7D50FA174DBEQ38120248-B81E1C13-1261-4FEF-A654-442E9646A7B9Q40058139-2BBA5C59-2F91-49B4-8DF4-38872887454FQ40707369-DBB998F6-1BC5-4102-A81C-483A5E786842Q42249703-228EA106-4B1D-4514-9A4D-FE71DFD4D52AQ42406771-F2C8836E-691E-4858-90D4-024524A4A6DEQ44321653-0B925AA0-ED94-4AC9-A766-FD6B1A751842Q44949104-E656E976-9748-41DB-8EFA-198CCBD32B32Q45733656-44E7301A-8CEC-40FF-9935-8DFB102FD1E3Q47142818-80FD3F00-989E-494D-8A76-5712917F3623Q47446439-F890B966-4DF5-4482-BAE9-A65D6F4A9CDAQ51346002-9AFDAF18-5E1D-422B-8325-B05B1F25D493Q52699076-4E1B7C0C-7098-45FF-BAD5-9C09AD55B9E1Q52854342-0BF16FE1-BEEE-4878-9345-A4D510806115Q54344622-CA86804B-AEA1-439B-9743-1A0C4BF048DCQ56997761-27C1397C-7A4D-40C4-A500-E77A65CE07E0Q58544636-B55BA45B-D460-42E0-997E-734C70907E4F
P2860
Predicting survival among patients listed for liver transplantation: an assessment of serial MELD measurements.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Predicting survival among pati ...... t of serial MELD measurements.
@en
Predicting survival among pati ...... t of serial MELD measurements.
@nl
type
label
Predicting survival among pati ...... t of serial MELD measurements.
@en
Predicting survival among pati ...... t of serial MELD measurements.
@nl
prefLabel
Predicting survival among pati ...... t of serial MELD measurements.
@en
Predicting survival among pati ...... t of serial MELD measurements.
@nl
P2093
P2860
P1476
Predicting survival among pati ...... nt of serial MELD measurements
@en
P2093
Charles B Rosen
E Rolland Dickson
Jeff Thostenson
Joanne T Benson
Kiran Bambha
Patrick S Kamath
Russell Wiesner
Terry M Therneau
Walter K Kremers
P2860
P304
P356
10.1111/J.1600-6143.2004.00550.X
P407
P50
P577
2004-11-01T00:00:00Z